Delivery Order SPE2DB22D1202-SPE2DB24FUST2

Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,852,096 units of Dexmethylphenidate ER 10 mg capsules. The contract has a potential value of $3,189.84 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside. This delivery order falls under a larger, single award indefinite...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,963,270 units of 10 mg dextromethylphenidate extended-release capsules. The $2,149.20 firm-fixed-price delivery order has a completion date of January 17, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,192.88 firm fixed-price delivery order is for the supply of 4,566,552,109 units of Dexmethylphenidate ER 10 mg capsules. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,108.70 firm fixed-price delivery order is for the supply of 100 units of 20 mg dextromethylphenidate extended-release capsules, a prescription medication. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 21, 2025. This delivery order is part of a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,535,551 units of dexmethylphenidate extended-release 20 mg capsules. The contract has a firm fixed price of $2,073.05 and a completion date of August 22, 2024. This is a delivery order contract, and there is no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is associated with the company's...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,135,189 units of Dexmethylphenidate ER 10 mg capsules. The $2,805.96 contract has an ultimate completion date of April 2, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its corporate office located in...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,564,118,189 units of Dexmethylphenidate ER 20 mg capsules, a prescription medication. The contract is a firm fixed price delivery order with a ceiling value of $1,716.09 and a period of performance through April 1, 2024. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,603,290 units of the drug dexmethylphenidate extended-release 10 mg capsules. The contract has a ceiling value of $1,063.28 and is a firm fixed-price delivery order contract that runs through March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,178.36 firm fixed-price delivery order contract is for the supply of 100 units of 15 mg dextromethylphenidate extended-release capsules. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract, valued at $1,860.53, is for the supply of dexmethylphenidate extended-release capsules in 5 milligram dosage. The contract has a completion date of September 13, 2024 and is structured as a Firm Fixed Price (FFP) arrangement. Amerisourcebergen, the prime contractor, does not have any subcontractors...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUST2
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distributor. The contract, valued at $1,975.42, is for the delivery of dextromethylphenidate extended-release 5 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 6/5/24, 9:54 AM